BELLUS Health Inc. (BLU): Sit Tight When Things Go Right – Stocks Register
Home  »  Finance   »  BELLUS Health Inc. (BLU): Sit Tight When Things Go...

BELLUS Health Inc. (BLU): Sit Tight When Things Go Right

BELLUS Health Inc. (NASDAQ:BLU) concluded the trading at $6.00 on Thursday, January 13 with a fall of -6.25% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $6.40 and 5Y monthly beta was reading -0.55 with its price kept floating in the range of $5.97 and $6.39 on the day. Considering stock’s 52-week price range provides that BLU hit a high price of $9.84 and saw its price falling to a low level of $2.60 during that period. Over a period of past 1-month, stock came subtracting -26.74% in its value.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


With its current market valuation of $641.40 million, BELLUS Health Inc. is set to declare its quarterly results on Feb 23, 2022 – Feb 28, 2022. Analysts are in estimates of -$0.26 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.88 for 2021 with estimates of that growing to -$0.87 in next year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review BLU stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 50% Buy for it.

According to ratings assigned by 9 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending BELLUS Health Inc. (BLU) as a Hold, while 9 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.

Digging deeper we become aware of the PEG ratio of the BLU stock which is currently positioned at 0. It further provides that stock’s current price level is -20.77% away from its 20-day simple moving average and is -12.51% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 34.75 while volatility remained at 5.53% over the past week which changes to 5.92% when measuring it over the past month. Beta is valued at 0.14, while measure of average true range or ATR is currently at 0.55.

Having a second look at BELLUS Health Inc. (NASDAQ:BLU) provides that stock’s average daily trading volume for 3 months was 3.05 million, while it jumped to 0.78 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 78.34 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

The percentage of outstanding shares held by the insiders is 3.30% while it is 73.24% for the institutional holders. The figures also indicate that as of Dec 14, 2021, number of stock’s short shares was 6.69 million which implies a short ratio of 0.97. This shows up a 8.54% of Short Interest in company’s outstanding shares on the day. In December the standing of shares short improved as it was 4.06 million in the previous month. Subtraction of -25.47% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam